Dermetel has elected to be held to the UK Corporate Governance Code 2018 from the Financial Reporting Council. Online Meetings are capped at 3 hours maximum and are scheduled every month for the rest of 2021 over Boardable, a leading, fully secure non-profit board management software provider. From 2022, we'll limit meetings to every other month. There's a lot to get through this year given the severe disruption Covid-19 has had on our timelines. 2021 issues: supplement distribution, hybrid clinical trials, the chronic illness management app, Utah-based manufacturing targets, what to do about the enzyme replacement therapy situation, consolidating/acquiring/testing the latest enzymes from the renegade academic researchers, developing larger tax incentives for donors, restarting the Dermetel Gala every year in London as our sole fundraising event at £10,000/single or £15,000/couple and capped at 2,000 people similar to how the Butterfly Ball in Monaco is run but considerably more aggressive in our fundraising, picking up the tempo regarding new website HIPAA compliant tech issues, etc.
All Board meetings will be the last Sunday of each month.
25 July 2021. Agenda: voting in the new MBA-trained Executive Director, reviewing manufacturing targets/budget, preliminary discussion of the supplement pilot, ClinicalTrials.gov progress, etc.
29 August 2021
26 September 2021
31 October 2021
28 November 2021
19 December 2021 (adjusted due to Boxing Day)
We're rounding out the new onboards for a total Board size of 11 people: 9 external and 2 internal, and we have multiple committees. We're lucky to have rare disease pharmaceutical industry executives from both Pfizer and Astra Zeneca as well as two Junior League-trained women with extensive post-deb experience and many other experienced leaders from other fields. It's a mix of US, Swiss, and UK-based leaders.
Annual Reports from 2011 to 2020 will be uploaded for public inspection in due course.